VV
Victoria Vakiener
Director

Victoria Vakiener insider trades: Arrowhead Pharmaceuticals (ARWR) stock sales

Director, Arrowhead Pharmaceuticals Last trade Dec 19, 2025 18 Form 4 filings
$679K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2021
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Victoria reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 19, 2025ARWR↓ Sell10b5-1$679K
Dec 16, 2024ARWR↓ Sell$197K
May 2, 2024ARWR↓ Sell$42K
Jan 11, 2024ARWR↓ Sell$180K
Sep 28, 2023ARWR↓ Sell$41K
Feb 4, 2021EPZM↓ Sell10b5-1$9K
Jan 25, 2021EPZM↓ Sell10b5-1$7K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ARWR insiders

Open-market trades in the last 12 months

About Victoria Vakiener's insider trades

Victoria Vakiener is a director at Arrowhead Pharmaceuticals (ARWR). Since Jan 25, 2021, Victoria has reported no open-market purchases and 7 sales worth $1.2M on SEC Form 4. In the last 12 months: 1 sale ($679K).

3 sales (60% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (10 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARWR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.